Related Experiment Video
Updated: May 23, 2026

The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve
Published on: September 7, 2022
Patient Preference Phenotypes for Post-operative Anticoagulation After Hip or Knee Replacement: A Cross-sectional
Leslie A Lenert1, Dmitry Scherbakov D2, Azza Shaoibi3
1Department of Internal Medicine, Medical University of South Carolina (MUSC), Charleston, SC, USA. Lenert@musc.edu.
Patients undergoing hip or knee replacement surgery have varied preferences for anticoagulation therapy. Three distinct patient subgroups emerged, influencing personalized treatment choices for preventing blood clots and other adverse events.
Area of Science:
- Orthopedic Surgery
- Pharmacology
- Health Economics
Background:
- Anticoagulation is crucial post-hip or knee replacement to prevent thrombosis-related events like pulmonary embolism.
- The Pulmonary Embolism Prevention after Hip and Knee Replacement (PEPPER) trial evaluates optimal anticoagulant strategies (aspirin, warfarin, rivaroxaban).
- Patient preferences significantly influence treatment adherence and outcomes, necessitating their consideration in therapy selection.
Purpose of the Study:
- To investigate the role of patient preferences in tailoring anticoagulant therapy after hip and knee replacement surgery.
- To identify distinct patient subgroups or preference phenotypes based on their valuation of anticoagulant risks and benefits.
- To inform individualized therapeutic approaches within the PEPPER trial and clinical practice.
Main Methods:
- A multimedia conjoint analysis (CA) survey was developed, incorporating expected probabilities of anticoagulant benefits and adverse effects.
- 192 post-hip and post-knee replacement patients eligible for the PEPPER trial were recruited and surveyed 1-7 months post-surgery.
- K-means clustering was employed to analyze patient data and characterize heterogeneity in preferences.
Main Results:
- Patients generally prioritized avoiding pulmonary embolism risk, followed by bleeding and venous thrombosis risks, though individual values varied significantly.
- Three distinct preference phenotypes were identified: thrombosis-focused (aligning with rivaroxaban), balanced (aligning with aspirin), and out-of-pocket cost-focused (aligning with aspirin or warfarin).
- These preference phenotypes showed minimal overlap, indicating clear distinctions in patient priorities regarding anticoagulation therapy.
Conclusions:
- Patient preferences for anticoagulation therapy differ significantly in the post-hip and post-knee replacement population.
- Conjoint analysis revealed three distinct preference phenotypes with implications for personalizing anticoagulant selection.
- Incorporating patient preferences can optimize anticoagulation strategies, potentially improving outcomes and adherence in joint replacement surgery patients.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...